Skip to main content
. 2021 Apr 13;98(1):37–42. doi: 10.1111/tan.14256

TABLE 1.

Clinical characteristics of the study patients, stratified by the disease severity

Characteristic All COVID‐19 patients (N = 178) Patients with severe disease (N = 73) Patients with nonsevere disease (N = 105)
Age (years)
Median (interquartile ranges) 57.5 (44.0–70.0) 68.0 (59.0–77.0) 49.0 (35.0–60.0)
Distribution no. (%)
20–29 years 17 (9.6) 0 (0.0) 17 (16.2)
30–39 years 18 (10.1) 1 (1.4) 17 (16.2)
40–49 years 30 (16.9) 9 (12.3) 21 (20.0)
50–59 years 30 (16.9) 10 (13.7) 20 (19.0)
60–69 years 33 (18.5) 20 (27.4) 13 (12.4)
70–79 years 32 (18.0) 19 (26.0) 13 (12.4)
80–89 years 15 (8.4) 11 (15.1) 4 (3.8)
90–99 years 3 (1.7) 3 (4.1) 0 (0.0)
Male sex no. (%) 106 (59.6) 47 (64.4) 59 (56.2)
Severity no. (%)
Mild: Symptomatic without pneumonia 30 (16.9) 30 (28.6)
Moderate: Symptomatic with pneumonia, no oxygen therapy 75 (42.1) 75 (71.4)
Severe: Symptomatic with pneumonia, conventional oxygen therapy 51 (28.7) 51 (69.9)
Critical: Admission to intensive care unit (ICU) or use of mechanical ventilation 22 (12.4) 22 (30.1)
Pre‐existing medical conditions—no. (%) a
Hypertension 48 (27.6) 30 (42.9) 18 (17.3)
Diabetes 33 (19.0) 24 (34.3) 9 (8.7)
Cardio vascular diseases 10 (5.7) 9 (12.9) 1 (1.0)
DRB1 genotype—no. (%) b
09:01/09:01 5 (2.8) 5 (6.8) 0 (0.0)
09:01/X 41 (23.0) 19 (26.0) 22 (21.0)
X/X 132 (74.2) 49 (67.1) 83 (79.0)
a

Information on pre‐existing medical conditions was acquired from 174 patients (70 severe cases and 104 nonsevere cases) with COVID‐19.

b

X stands for any other DRB1 allele.